Loading...

Purified anti-mouse CD31 Antibody

Pricing & Availability
Clone
MEC13.3 (See other available formats)
Regulatory Status
RUO
Other Names
PECAM-1, EndoCAM
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
MEC13dot3_Purified_080607
C57BL/6 mouse splenocytes stained with purified MEC13.3, followed by anti-rat IgG FITC
  • MEC13dot3_Purified_080607
    C57BL/6 mouse splenocytes stained with purified MEC13.3, followed by anti-rat IgG FITC
Compare all formats
Cat # Size Price Quantity Check Availability Save
102501 50 µg 57€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
102502 500 µg 205€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD31 is a 130-140 kD glycoprotein, also known as platelet endothelial cell adhesion molecule (PECAM-1), EndoCAM, and gpIIa. It is a member of the Ig superfamily, expressed on endothelial cells, platelets, granulocytes, monocytes/macrophages, dendritic cells, and T and B cell subsets, and is critical for cell-to-cell interactions. The primary ligands for CD31 have been reported to be CD38 and the vitronectin receptor (αv β3 integrin, CD51/CD61). Other reported functions of CD31 are neutrophil emigration to sites of inflammation, and angiogenesis.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Polyoma middle T transformed EC line tEnd.1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IP, Block, IHC-F - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Anti-mouse CD31 clones 390 and MEC13.3 bind to their respective non-overlapping epitopes in IgD2 of CD31.8 Additional reported applications (in the relevant formats) include: immunoprecipitation1, in vitro and in vivo blocking of CD31-mediated cell-cell interactions1-4, immunohistochemical staining1,5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)12,13.
Special Note: The antibody works well on acetone-fixed frozen sections as well as Zinc-fixed paraffin-embedded sections. It sometime works on formalin-fixed and paraformaldehyde-fixed paraffin-embedded tissue sections but inconsistent results have been reported. This antibody is not recommended for formalin-fixed paraffin-embedded sections or for Western blot analysis. The Ultra-LEAF™ Purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 102529 and 102530).

Application References
  1. Vecchi A, et al. 1994. Eur. J. Cell Biol. 63:247. (IP, IHC, Block)
  2. Christofidou-Solomidou M, et al. 1997. J. Immunol. 158:4872. (Block)
  3. DeLisser HM, et al. 1997. Am. J. Pathol. 151:671. (Block)
  4. Rosenblum WI, et al. 1994. Am. J. Pathol. 145:33. (Block)
  5. Baldwin HS, et al. 1994. Development 120:2539. (IHC)
  6. Voswinckel R, et al. 2003. Circ. Res. 93:372. (IHC)
  7. Leung VW, et al. 2009. Am J. Pathol. 175:1757. PubMed
  8. Chacko AM, et al. 2012. PLoS One 7:e34958.
  9. Giacomini C, et al. 2014. Exp Eye Res. 18:1. PubMed
  10. Morita R, et al. 2015. PNAS. 112:160. PubMed
  11. Ito A, et al. 2015. Brain Res. 1594:310. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  2. Tremblay M, et al. 2020. Elife. 9: . PubMed
  3. Moore ER, et al. 2021. Bone. 143:115738. PubMed
  4. Fu A, et al. 2022. Cell. 185:1356. PubMed
  5. Fuglerud BM, et al. 2022. Nucleic Acids Res. 50:8547. PubMed
  6. Georgieva JV, et al. 2022. Pharmaceutics. 14: . PubMed
  7. Ngwa VM, et al. 2022. Cancer Res Commun. 2:694. PubMed
  8. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  9. Mahmud N, et al. 2022. Cell Rep. 41:111853. PubMed
  10. Bai Q, et al. 2023. J Pers Med. 13: . PubMed
  11. Citro A, et al. 2023. Nat Commun. 14:878. PubMed
  12. Betterman KL, et al. 2020. J Clin Invest. 130:3315. PubMed
  13. Brenner JS, et al. 2018. Nat Commun. 9:20222. PubMed
  14. Todd L, et al. 2019. J Neuroinflammation. 16:118. PubMed
  15. Shafer MER, et al. 2017. Stem Cell Reports. 1.040277778. PubMed
  16. Lei L, et al. 2020. Stem Cell Res Ther. 11:137. PubMed
  17. Schnoor M, et al. 2011. J Exp Med. 208:1721. PubMed
  18. Zanini F, et al. 2023. iScience. 26:106097. PubMed
  19. Song J, et al. 2023. iScience. 26:106753. PubMed
  20. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  21. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  22. Liu X et al. 2019. Immunity. 50(2):317-333 . PubMed
  23. Challa DK, et al. 2019. MAbs. 11:848. PubMed
  24. Marchant C, et al. 2020. Development. 147:00:00. PubMed
  25. Liu Y, et al. 2019. J Cell Physiol. 234:9525. PubMed
  26. Juan T, et al. 2009. Clin Cancer Res. 3.819444444. PubMed
  27. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  28. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  29. Lobo P, et al. 2012. J Immunol. 188:1675. PubMed
  30. Dooley J, et al. 2020. Cell Rep. 32:107880. PubMed
  31. Yang X, et al. 2020. Cell Biosci. 0.488194444. PubMed
  32. Carr MJ, et al. 2019. Cell Stem Cell. 24:240. PubMed
  33. Song A, et al. 2018. Sci Rep. 8:723. PubMed
  34. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  35. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  36. Opzoomer JW, et al. 2021. Sci Adv. 7:eabg9518. PubMed
  37. Woyciechowski S, Hofmann M, Pircher H 2017. Eur J Immunol. 47:244-250. PubMed
  38. Na YR, et al. 2020. Cell Rep. 107643:31. PubMed
  39. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  40. Crosse EI, et al. 2020. Cell Stem Cell. 27:822. PubMed
  41. Fu H, et al. 2019. Front Immunol. 10:271. PubMed
  42. Sun W, et al. 2021. Mol Ther. 29:1312. PubMed
  43. Hansmeier NR, et al. 2022. Int J Mol Sci. 23:. PubMed
  44. Arumugam R, et al. 2020. Immunobiology. 151896:225. PubMed
  45. Shiuan E, et al. 2020. F1000Research. 0.525694444. PubMed
  46. Zhou Z, et al. 2022. Life (Basel). 12:. PubMed
  47. Cardoso F, et al. 2021. Nature. 597:410. PubMed
  48. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  49. Maul A, et al. 2022. Elife. 11:. PubMed
  50. Takahashi K, et al. 2020. J Biol Chem. 295:12559. PubMed
  51. Kuboi Y, et al. 2019. Int Immunol. 31:287. PubMed
  52. Poulos MG, et al. 2017. J Clin Invest. 127:4163. PubMed
  53. Andreev D, et al. 2020. J Clin Invest. 130:4811. PubMed
  54. Ohnuki H, et al. 2012. Blood. 119:2688. PubMed
  55. Matsumoto A, et al. 2021. iScience. 24:102839. PubMed
  56. Koch PS, et al. 2021. Front Physiol. 12:722394. PubMed
  57. Lee C, et al. 2020. J Shoulder Elbow Surg. 719:29. PubMed
  58. Ito A, et al. 2015. Brain Res. 1594:310. PubMed
  59. Sun JX, et al. 2018. Angiogenesis. 8:2407. PubMed
  60. Zlotoff D, et al. 2011. Blood. 118:1962. PubMed
  61. Heil J, et al. 2021. Nat Commun. 12:6963. PubMed
  62. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  63. Zakharova I, et al. 2022. Front Bioeng Biotechnol. 10:772981. PubMed
  64. Giacomini C, et al. 2014. Exp Eye Res. 18:1. PubMed
  65. Cheung K, et al. 2015. Proc Natl Acad Sci U S A. 112: E5815 - E5824. PubMed
  66. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  67. Storer MA, et al. 2020. Developmental Cell. 52(4):509-524.e9.. PubMed
  68. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  69. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  70. Baluk P, et al. 2022. Methods Mol Biol. 2441:115. PubMed
  71. Kolb R, et al. 2016. Nat Commun. 7:13007. PubMed
  72. Fierle JK, et al. 2021. Cell Reports Medicine. 2(8):100362. PubMed
  73. Lee C, et al. 2020. J Orthop Res. 1159:38. PubMed
  74. Figueiredo CA, et al. 2022. J Neuroinflammation. 19:17. PubMed
  75. Morita R, et al. 2015. Proc Natl Acad Sci U S A. 112:160. PubMed
  76. Huynh H, et al. 2019. Int J Oncol. 54:1123. PubMed
  77. Kabir AU, et al. 2018. JCI Insight. 3. PubMed
RRID
AB_312908 (BioLegend Cat. No. 102501)
AB_312908 (BioLegend Cat. No. 102502)

Antigen Details

Structure
Ig superfamily, 130-140 kD
Distribution

Endothelial cells, platelets, granulocytes, monocytes/macrophages, dendritic cells, T and B cell subsets

Function
Adhesion
Ligand/Receptor
CD38, αV/β3 integrin
Cell Type
B cells, Dendritic cells, Endothelial cells, Granulocytes, Macrophages, Monocytes, Neutrophils, Platelets, T cells
Biology Area
Angiogenesis, Cell Adhesion, Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. DeLisser HM, et al. 1994. Immunol. Today 15:490.
3. Newman PJ, et al. 1990. Science 247:1219.

Gene ID
18613 View all products for this Gene ID
UniProt
View information about CD31 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 07-19-2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account